Thymosin α1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts

被引：52

作者：

Li, CL ^{[1
]}

Zhang, T ^{[1
]}

Saibara, T ^{[1
]}

Nemoto, Y ^{[1
]}

Ono, M ^{[1
]}

Akisawa, N ^{[1
]}

Iwasaki, S ^{[1
]}

Maeda, T ^{[1
]}

Onishi, S ^{[1
]}

机构：

[1] Kochi Med Sch, Dept Med, Nankoku, Kochi 7838505, Japan

来源：

INTERNATIONAL IMMUNOPHARMACOLOGY | 2002年 / 2卷 / 01期

关键词：

hepatitis B virus; thymosin; thymus; 5-FU; hedgehog;

D O I：

10.1016/S1567-5769(01)00136-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Thymosin alpha1 is a biological response modifier that has been used clinically for the treatment of chronic hepatitis B viral infection. Both immunomodulatory and immediate intracellular mechanisms have been postulated to explain the effect of thymosin alpha1 on hepatocytes infected with hepatitis B virus (HBV). Here, we established a new animal model and the related suitable conditions to access the thymosin activity by means of measuring the production of neutralizing antibody against hepatitis B surface antigen (HBsAg). We proved that chemically synthesized thymosin alpha1 restored the T cell-mediated antibody production following its suppression in mice by 5-fluorouracil (5-FU), and found that thymosin alpha1 showed activity at a low dose of 30 mug/kg. Further studies utilizing the flowcytometric analysis showed that thymosin alpha1 at this dose accelerated the replenishment and maturation of thymocytes while the expression of Smoothened (Smo) of the Hedgehog (Hh)-signaling in CD4(-)CD8(-) thymocytes, the potent negative regulator of proliferative responses, was not affected. The restoration of some of the defects in the host defense systems may facilitate elimination of infectious agents, and the present study provides a novel model to define the restoration of T cell-mediated immune responses to hepatitis B virus in vivo. (C) 2002 Elsevier Science BN. All rights reserved.

引用

页码：39 / 46

页数：8

共 27 条

[1] Thymosin alpha-1 [J].